Further Information:
The Health Products Regulatory Authority has been notified of a shortage of the following products:
- BCG-Medac Powder and Solvent for Suspension for Intravesical Use – PA0623/004/001
- Citalopram 40mg Tablet – PA0749/019/003
- Colomycin Injection 1 Million IU Powder for Solution for Injection, Infusion or Inhalation – PA1986/046/001
- Difene 25mg Capsule – PA2256/001/001
- Erythroped SF 250mg/5ml Granules for Oral Suspension – PA1142/006/001
- HBVAXPRO 40mcg/ml Suspension for Injection – EU/1/01/183/015
- Lercandipine Mylan 10mg Tablet – PA0577/155/001
- Lercandipine Mylan 20mg Tablet – PA0577/155/002
- Livial 2.5mg Tablet – PA1286/059/001
- Pneumovax 23 Solution for Injection in Pre-Filled Syringe – PA1286/055/002
- Tefin 75mg Suppositories – PA1684/001/001
- Tefin 150mg Suppositories – PA1684/001/002
- Temozolomide 250mg Capsule – EU/1/09/606/011-012
- Warticon 0.15% w/w Cream – PA1113/017/001
- Zimovane 7.5mg Film Coated Tablet – PA2010/057/001
The following shortage has been resolved and supply has resumed to the Irish market:
- Dalacin 2% Vaginal Cream – PA0822/119/002
- Isoptin 40mg Film Coated Tablet – PA2010/003/001
- Septrin Adult 80mg/400mg Oral Suspension – PA1691/010/004
- Sotoger 80mg Tablet – PA0577/021/001
- Surmontil 50mg Capsule – PA0540/128/003
- Tractocile 6.75mg/0.9ml Solution for Injection – EU/1/99/124/001
- Zineryt 40mg + 12mg Powder and Solvent for Cutaneous Solution – PA0046/065/001
Please see the shortages section of the HPRA website for further information.
The HPRA will be sending weekly updates concerning medicinal product shortages. However, the above webpage will be updated in real time.